NasdaqGS - Nasdaq Real Time Price USD
Legend Biotech Corporation (LEGN)
27.91
+0.13
+(0.47%)
As of 10:27:50 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 2 | 4 |
| Avg. Estimate | -0.22 | -0.11 | -0.64 | 0.69 |
| Low Estimate | -0.24 | -0.22 | -0.88 | 0.29 |
| High Estimate | -0.21 | -0.03 | -0.39 | 1.71 |
| Year Ago EPS | -0.1 | -0.68 | -0.96 | -0.64 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 21 | 21 |
| Avg. Estimate | 239.45M | 270.27M | 1.02B | 1.55B |
| Low Estimate | 215M | 235M | 925.05M | 1.22B |
| High Estimate | 344.05M | 300M | 1.16B | 1.85B |
| Year Ago Sales | 186.52M | 160.21M | 627.24M | 1.02B |
| Sales Growth (year/est) | 28.37% | 68.70% | 62.81% | 51.45% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.42 | -0.6 | -0.34 | -0.28 |
| EPS Actual | -0.1 | -0.68 | 0.14 | -0.54 |
| Difference | 0.32 | -0.08 | 0.49 | -0.26 |
| Surprise % | 75.98% | -12.80% | 140.58% | -92.86% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.22 | -0.11 | -0.64 | 0.69 |
| 7 Days Ago | -0.23 | -0.18 | -0.76 | 0.71 |
| 30 Days Ago | -0.23 | -0.18 | -0.76 | 0.71 |
| 60 Days Ago | -0.25 | -0.2 | -0.93 | 0.7 |
| 90 Days Ago | -0.31 | -0.27 | -0.75 | 1.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 4 | 3 | 2 | 4 |
| Up Last 30 Days | 4 | 2 | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LEGN | -123.64% | 84.47% | 33.80% | 208.60% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 5/14/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 5/14/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 4/22/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/16/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/8/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 3/17/2025 |
Related Tickers
XENE Xenon Pharmaceuticals Inc.
30.49
+0.64%
ACLX Arcellx, Inc.
56.79
-3.39%
CYTK Cytokinetics, Incorporated
30.37
-2.03%
CRNX Crinetics Pharmaceuticals, Inc.
30.62
-1.98%
AKRO Akero Therapeutics, Inc.
37.65
-3.14%
PCVX Vaxcyte, Inc.
31.74
-0.36%
HALO Halozyme Therapeutics, Inc.
52.35
+0.63%
BBIO BridgeBio Pharma, Inc.
32.76
-3.19%
TVTX Travere Therapeutics, Inc.
16.64
-0.95%
RVMD Revolution Medicines, Inc.
38.71
-2.11%